IMMUNOCOMPETENCE AND MALIGNANT-LYMPHOMA - IMMUNOLOGICAL STATUS BEFORE THERAPY
IMMUNOCOMPETENCE AND MALIGNANT-LYMPHOMA - IMMUNOLOGICAL STATUS BEFORE THERAPY
复制标题
DOI:
10.1002/1097-0142(19811215)48:12
复制
发表时间:
1981-01-01
期刊:
影响因子:
6.2
通讯作者:
STANLEY, P
中科院分区:
文献类型:
--
作者:
ANDERSON, TC;JONES, SE;STANLEY, P
Previously untreated patients (186) with malignant lymphoma were evaluated for immunocompetence by several tests of immune function; total circulating lymphocytes, T cells (E-rosettes), B cells (EAC-rosettes), delayed hypersensitivity to 6 recall antigens, serum Ig, mixed lymphocyte culture and lymphocyte mitogenic response to phytohemagglutinin and pokeweed mitogen. The results were correlated with histology, stage and clinical features. Diffuse lymphomas, especially diffuse histiocytic (large cell) (DHL), were associated with decreased absolute lymphocytes and E-rosette forming cells. Skin test reactivity varied with histology and state. Only 1 of 6 tests was impaired in diffuse lymphocytic well differentiated (DLWD) lymphoma in contrast to 2 of 6 in localized DHL and 5 of 6 in advanced DHL. Patients with nodular lymphoma exhibited depressed mean levels of IgA and IgG whereas only IgA was significantly decreased in diffuse lymphoma. Mitogen stimulation was depressed in all groups although mixed lymphocyte cultures did not differ significantly from controls. There is a spectrum of immunodeficiency of both B and T cell type in patients with malignant lymphoma that correlates with histology and stage. Implications and possible mechanisms of these observations are discussed.